SynthesisBMC ophthalmology2025
Prevalence of dry eye disease in African populations: a systematic review and meta-analysis.
Synthesis in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled prevalence of symptomatic dry eye and its associated factors among adults in Africa: (2016-2025) systematic review and meta-analysis study.Archives of public health = Archives belges de sante publique · 2026Pooled it
- The burden of keratoconjunctivitis sicca in Nigeria: a scoping review of prevalence and risk factors.International ophthalmology · 2026Article
- Therapeutic Effects of Glycyrrhizic Acid on Dry Eye Disease: Targeting Pyroptosis, Oxidative Stress, and Epithelial Barrier Dysfunction.International journal of molecular sciences · 2026Article
- Experience with ocular surface disease index analysis to assess dry eye disease and related conditions in Lagos, Nigeria.The Pan African medical journal · 2026Article
- Temperature, Humidity and Regional Prevalence of Dry Eye Disease in Argentina.Medicina (Kaunas, Lithuania) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDry eye disease (DED) is a prevalent ocular surface disorder that compromises vision-related function and overall quality of life. Data about African populations are scanty and episodic.
objectiveTo systematically estimate the pooled prevalence of Dry eye disease in African Populations, asses differences by region and diagnostic methodology, and discus implications for clinical practice and public health.
methodsWe conducted a PRISMA 2020 systematic review and meta-analysis. We conducted a structured PubMed, Google Scholar, AJOL, ResearchGate, and university repository search for observational studies that had reported prevalence of DED among African populations. Inclusion and exclusion were performed. Data extraction, quality appraisal using the JBI checklist, and meta-analysis using a random-effects model with logit transformation were conducted. Heterogeneity and publication bias were examined.
resultsFifteen studies involving 7,000 + individuals from eight countries of Africa were included. The overall prevalence of DED was 43.6% (95% CI: 34.2%–46.1%), with notable inter-country heterogeneity (range: 30.7% in Egypt to 86.5% in South Africa). Moderate heterogeneity (Q = 10.375, p = 0.110) was present. Funnel plot and Egger's test (p < 0.001) indicated possible publication bias. Conclusion: DED is very prevalent in Africa, with extensive regional diversity. Standardized diagnosis and improved surveillance are needed.
conclusionDry eye disease in highly prevalent in Africa, with significant regional variations driven by environment and diagnostic inconsistencies. Standardized diagnostic criteria greater awareness, and integrating DED into public health policy, research and clinical training are needed to mitigate its impact on vision and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.